The quest for vaccines: an unprecedented rally
How to reconcile speed, efficacy and safety?
Who should pay for what?
Therapeutic antibodies vs. vaccines: do we need both?
European strengths and weaknesses
Co-director of the I3h Institute (ULB)
Former Vice-Governor of the National Bank of Belgium
CEO, Bioaster, France
Co-director of the I3h Institute
Former Executive Director of the Innovative Medicines Initiative
Senior Fellow, Graduate Institute for International and Development Studies, Geneva
Former Executive Director of the Global Fund against HIV, Malaria and Tuberculosis
Professor at the Center of Vaccinology of the University of Geneva
Former Chief of Vaccines Research and Development at WHO
Director of Medicine Law and Policy and Founder of the Medicines Patent Pool
Chief Scientist & Head of external R&D, GSK Vaccines